IceCure Medical Ltd (ICCM) vs MBody AI Ltd. (MBAI)
A side-by-side comparison of IceCure Medical Ltd and MBody AI Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ICCM
IceCure Medical Ltd
$1.49HealthcareDelayed quote: Oct 6, 2026, 10:23 AM EDT
MBAI
MBody AI Ltd.
$3.20HealthcareDelayed quote: Oct 6, 2026, 10:23 AM EDT
Total return — ICCM vs MBAI
growth of $100 · dividends reinvested · last 1yICCM -92.8% (-92.8%/yr)MBAI -67.4% (-67.4%/yr)MBAI compounded faster over this window
ICCM MBAI
ICCM vs MBAI: by the numbers
- •ICCM is the larger company ($3M vs $3M market cap).
- •Both run net losses; MBAI's is the smaller (0.00% vs -427.67% net margin).
Metrics side by side
Valuation
| Metric | ICCM | MBAI |
|---|---|---|
| P/S ratio | 0.85 | N/A |
| P/B ratio | 0.28 | 0.93 |
Profitability
| Metric | ICCM | MBAI |
|---|---|---|
| Gross margin | 36.10% | 0.00% |
| Operating margin | -446.70% | 0.00% |
| Net margin | -427.67% | 0.00% |
| ROE | -141.90% | 120.45% |
| ROIC | -184.27% | -69.04% |
Growth (annualized)
| Metric | ICCM | MBAI |
|---|---|---|
| Revenue CAGR (5Y) | -0.69% | N/A |
| Total return CAGR (5Y) | -63.05% | N/A |
Go deeper
Dig into the metrics
IceCure Medical ROEMBody AI ROEIceCure Medical operating marginMBody AI operating marginIceCure Medical revenue growthMBody AI revenue growthIceCure Medical free cash flowMBody AI free cash flow
IceCure Medical & MBody AI appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.